Journals / İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi / 2017 / Cilt: 24 - Sayı: 1

Sarcopenia and clinical presentation

Pages
121–126
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review sarcopenia, which is a common but sometimes misdiagnosed condition in clinical practice, is discussed in the light of current knowledge.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sarcopenia is characterized by the progressive generalized loss of muscle function, quality, strength and mass.
📊
Key Findings & Data:The exact etiology is unknown, but the most commonly suggested contributory factors are a decrease in protein synthesis, mitochondrial dysfunction, reactive oxygen products, chronic inflammation, nutritional deficiency, loss of perfusion, age-related neuromuscular alterations, decrease in sex hormone, growth hormone (GH), insulin-like growth factor (IGF-1) and vitamin D levels together with physical inactivity.There are severe negative effects on quality of life and the individual’s socio-economic status and thus, sarcopenia is a significant public health problem.
💡
Conclusion & Impact:In this review sarcopenia, which is a common but sometimes misdiagnosed condition in clinical practice, is discussed in the light of current knowledge.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Sarcopenia is characterized by the progressive generalized loss of muscle function, quality, strength and mass. Although it is known as a primary geriatric disease, it may also develop in younger individuals secondary to immobilization, malnutrion and cachexia. The exact etiology is unknown, but the most commonly suggested contributory factors are a decrease in protein synthesis, mitochondrial dysfunction, reactive oxygen products, chronic inflammation, nutritional deficiency, loss of perfusion, age-related neuromuscular alterations, decrease in sex hormone, growth hormone (GH), insulin-like growth factor (IGF-1) and vitamin D levels together with physical inactivity.There are severe negative effects on quality of life and the individual’s socio-economic status and thus, sarcopenia is a significant public health problem. Sarcopenia is strongly correlated with the increased fragility that develops in the elderly and is a significant risk factor and also an indicator of disability and mortality. The evaluation of muscle strength and physical performance is mandatory for the diagnosis of sarcopenia. Despite the lack of a definitive treatment method, the most commonly accepted approaches include physical activity, nutritional supplementation therapy, and hormonal and new pharmacological agents. In this review sarcopenia, which is a common but sometimes misdiagnosed condition in clinical practice, is discussed in the light of current knowledge.

🔖

Cite This Article

ERSOY, Y., YİLDİRİM, T., GÜNDÜZ, H. D. (2022). Sarcopenia and clinical presentation. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi, Cilt: 24 - Sayı: 1, 121–126. https://ajindex.com/articles/549136

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Brose A, Parise G, Tarnopolsky MA. Creatine supplementation enhances isometric strength and body composition improvements following strength and body composition improvements following strength exercise training in older adults. J Gerontol A Biol Sci Med Sci 2003;58:11-9.3. Lynch JE, Henderson NR, Ramage L, McMurdo ME, Witham MD. Association between statin medication use and improved outcomes during inpatient rehabilitation in older people. Age Ageing 2012;41:260-2.
  2. Burton LA, Sumukadas D. Optimal management of sarcopenia. Clin Interv Aging 2010;5:217-28.
  3. Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J. The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2014;99(11):4336-45.
  4. Zachwieja JJ, Toffolo G, Cobelli C, Bier DM, Yarasheski KE. Resistance exercise ang growth hormone administration in older men: effect on insulin sensitivity and secretion during a stablelable intravenosus glucose tolerance test. Metabolism 1996;45:254-60.
  5. Waters DL, Baumgartner RN, Garry PJ, Vellas BAdvangates of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging 2010;5:259-70.
  6. Sullivan DH, Roberson PK, Johnson LE, Bishara O, Evans WJ, Smith ES. Effects of muscle strength training and testosteron in frail elderly men. Med Sci Sports Sci 2005;37:1664-72.
  7. Denison HJ, Cooper C, Sayer AA, Robinson SM. Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin Interv Aging 2015;10:859-69.
  8. Volpi E, Mittendorfer B, Rasmussen BB, Wolfe RR. The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab 2000;85:4481-90. Tieland M, van de Rest O, Dirks ML, van der Zwaluw N, Mensink M, van Loon LJ. Protein supplementation improves physical performance in frail elderly people: A randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012;13:720-6.
  9. C.P.Sharp, D.R.Pearson.’’Amino acid supplements and recovery from high-intensity resistamce training,’’journal of Strength-Conditioning Research 2010;24(4):1125-30.
  10. Morley JE, Argiles JM, Evans WJ, Bhasin S, Cella D, Deutz NE. Society for Sarcopenia, Cachexia, and Wasting Disease. Nutritional recommendations fort he man